Trial NCT03483883

View at ClinicalTrials.gov 
Org. Study IDs: UPCC 02818

Last trial update was posted on 2022-08-26

MeSH Interventions

Avelumab Gemcitabine

MeSH Conditions


Other Conditions

Metastatic sRCC

Stopping Reasons

The study was terminated due to protracted accrual and limited patient engagement in the setting of rapidly changing treatment paradigms for advanced RCC with sarcomatoid features and/or intermediate/poor risk clinical features.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID